Tolerance Bio, Inc. is a biopharmaceutical company developing thymus-based therapies and iPSC-based cell treatments for immune-mediated diseases like cancer, autoimmunity, and transplant rejection.

Tolerance Bio, Inc. is a biopharmaceutical company developing thymus-based therapies and iPSC-based cell treatments for immune-mediated diseases like cancer, autoimmunity, and transplant rejection.

PolicyMap, Inc. is a provider of geographic data and analytics services, offering a platform for market intelligence, site selection, impact evaluation, and academic research to various organizations including government, healthcare, banking, and educational institutions.